- Home
- APAM vs VKTX Comparison
APAM vs VKTX Comparison
Compare APAM & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APAM
- VKTX
- Stock Information
- Founded
- APAM 1994
- VKTX 2012
- Country
- APAM United States
- VKTX United States
- Employees
- APAM N/A
- VKTX N/A
- Industry
- APAM Investment Managers
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- APAM Finance
- VKTX Health Care
- Exchange
- APAM Nasdaq
- VKTX Nasdaq
- Market Cap
- APAM 3.1B
- VKTX 3.4B
- IPO Year
- APAM 2013
- VKTX 2015
- Fundamental
- Price
- APAM $42.20
- VKTX $34.07
- Analyst Decision
- APAM Hold
- VKTX Strong Buy
- Analyst Count
- APAM 4
- VKTX 14
- Target Price
- APAM $44.38
- VKTX $97.29
- AVG Volume (30 Days)
- APAM 469.1K
- VKTX 4.8M
- Earning Date
- APAM 02-04-2025
- VKTX 02-05-2025
- Dividend Yield
- APAM 8.24%
- VKTX N/A
- EPS Growth
- APAM 14.74
- VKTX N/A
- EPS
- APAM 3.66
- VKTX N/A
- Revenue
- APAM $1,111,800,000.00
- VKTX N/A
- Revenue This Year
- APAM $6.22
- VKTX N/A
- Revenue Next Year
- APAM $7.11
- VKTX $986.87
- P/E Ratio
- APAM $11.53
- VKTX N/A
- Revenue Growth
- APAM 14.02
- VKTX N/A
- 52 Week Low
- APAM $37.89
- VKTX $28.64
- 52 Week High
- APAM $49.54
- VKTX $99.41
- Technical
- Relative Strength Index (RSI)
- APAM 38.14
- VKTX 51.41
- Support Level
- APAM $42.84
- VKTX $28.90
- Resistance Level
- APAM $44.73
- VKTX $34.37
- Average True Range (ATR)
- APAM 1.26
- VKTX 2.37
- MACD
- APAM -0.16
- VKTX 0.66
- Stochastic Oscillator
- APAM 13.05
- VKTX 70.06
About APAM Artisan Partners Asset Management Inc.
Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.